Top Markets
Coin of the day
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.

RGRX
Kedudukan dalam Saham #42502
RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the... RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the advancement of therapeutic peptides, with a primary emphasis on thymosin beta 4, engineered for the protection, repair, and regeneration of tissues and organs. The company's development pipeline includes RGN-259, a preservative-free ophthalmic solution designed to restore corneal tissues following injury, disease, or other pathologies; RGN-352, an injectable formulation under investigation for its potential in treating cardiovascular ailments, central and peripheral nervous system disorders, and various other medical conditions; and RGN-137, a topical gel aimed at accelerating the healing of skin wounds and minimizing scar tissue. Strategic alliances have been forged with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. Incorporated in 1982, the company initially operated as Alpha 1 Biomedicals, Inc., adopting the name RegeneRx Biopharmaceuticals, Inc. in 2000. Its operations are headquartered in Rockville, Maryland.
Harga Saham
$0.0007
Disegerakkan terakhir: 2026-08-11
Modal Pasaran
$1.05K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
250.00%
Negara
US
Perdagangan RegeneRx Biopharmaceuticals, Inc. (RGRX)

Kategori

Sejarah pecahan saham untuk RegeneRx Biopharmaceuticals, Inc. (RGRX)
Saham RegeneRx Biopharmaceuticals, Inc. (simbol: RGRX) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 12, 2026.
Satu saham RGRX yang dibeli sebelum Aug 12, 2026 kini bersamaan dengan 0 saham RGRX.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR